Home
Up

DHEA
DHEA (dehydroepiandrosterone) is synthesized primarily in the adrenal glands from the steroid precursor pregnenolone which is synthesized from cholesterol. DHEA is the main precursor for estradiol and testosterone. In the blood most DHEA is sulfated (DHEA-S04) providing a storage depot for DHEA, thereby prolonging its half life and providing a steady state source of DHEA for conversion to estrogens and androgens in the adrenal glands, ovaries, and testes.

Circulating levels are closely associated with aging, dropping nearly five-fold from a peak at age 20-25 to a low at age 70-80. Various diseases such as osteoporosis, CVD, AIDS, autoimmune disease (i.e. lupus), Alzheimer’s disease, breast cancer, thyroid disease, and diabetes have been associated with low circulating DHEA levels.

It has been suggested that measures which increase circulating DHEA levels such as exercise, proper diet, stress reduction, and/or supplementation can ameliorate some of the diseases associated with low DHEA levels, especially the generalized debilitation associated with aging. Although such debilitation is multifactorial, measurement of DHEA allows identification of low levels as a possible contributing factor and a means to follow specific intervention.

Interpretation of Results
DHEA levels in saliva reflect active DHEA and not DHEA-SO4. Patients on transdermal DHEA creams may have high DHEA levels.

Age and Sex Specific Ranges for DHEA in Saliva
(Unsupplemented A.M. Ranges in pg/ml)

    Female                                                             Male
    Age                     Range                                    Age                 Range
  20 - 29                106 - 300                                 20 - 29             137 - 336
  30 - 39                  77 - 217                                 30 - 39               82 - 287
  40 - 49                  47 - 200                                 40 - 49               68 - 221
  50 - 59                  38 - 136                                 50 - 59               49 - 177
  60 - 69                  36 - 107                                 60 - 69               40 - 158
  70 - 79                  32 -  99                                  70 - 79               35 - 135
       >80                 33 -  90                                       >80               37 - 106

References
1) Barrett-Connor E, K-T Khaw, Yen SSC: A prospective study of dehydroepiandrosterone sulfate, mortality, and cardiovascular disease. N Engl J Med 1986;315:1519-1524
2) Regelson W, Lovia R, Kalimi M: Hormonal intervention: "buffer hormones" or "state dependency". The role of dehydroepiandrosterone (DHEA), thyroid hormone, estrogen and hypophysectomy in aging. Ann NY Acad Sci 1988;521:260-273
3) Monroe S E, Menon K M J: Changes in reproductive hormone secretion during the climacteric and postmenopausal periods. Clin Obstet Gynecol 1977;20:113-122
4) Swinkels LM, Ross HA, Smals AG, Benraad TF: Concentrations of Total and Free Dehydroepiandrosterone in Plasma and Dehydroepiandrosterone in Saliva of Normal and Hirsute Women Under Basal Conditions and During Administration of Dexamethasone/Synthetic Corticotropin. Clin Chem 1990;36:2042-2046

Copyright © Aeron Biotechnology Inc., all rights reserved